Real-world effectiveness of GLP-1 receptor agonist-based treatment strategies on “time in range” in patients with type 2 diabetes

Background: Diabetes affects millions of people worldwide annually, and several methods, including medications, are used for its management; glucagon-like peptide-1 receptor agonists (GLP-1RAs) are one such class of medications. The efficacy and safety of GLP-1RAs in treating type 2 diabetes mellitu...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Yongru Chen, Jingxian Chen, Shuo Zhang, Dan Zhu, Feiying Deng, Rui Zuo, Yufei Hu, Yue Zhao, Yale Duan, Benwei Lin, Fengwu Chen, Yun Liang, Jiaxiong Zheng, Barkat Ali Khan, Kaijian Hou
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2024-03-01
Colecção:	Frontiers in Pharmacology
Assuntos:	type 2 diabetes time in range glucagon-like peptide-1 receptor agonists continuous glucose monitoring oral antidiabetic drugs
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fphar.2024.1370594/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!